DK449183D0 - Fremgangsmade til fremstilling af ortho-substituerede dihydroxy-2(1h)quinazolinon-1-alkansyrer - Google Patents

Fremgangsmade til fremstilling af ortho-substituerede dihydroxy-2(1h)quinazolinon-1-alkansyrer

Info

Publication number
DK449183D0
DK449183D0 DK4491/83A DK449183A DK449183D0 DK 449183 D0 DK449183 D0 DK 449183D0 DK 4491/83 A DK4491/83 A DK 4491/83A DK 449183 A DK449183 A DK 449183A DK 449183 D0 DK449183 D0 DK 449183D0
Authority
DK
Denmark
Prior art keywords
quinazolinon
substituted dihydroxy
preparing ortho
alkanic acids
alkanic
Prior art date
Application number
DK4491/83A
Other languages
English (en)
Other versions
DK159311C (da
DK449183A (da
DK159311B (da
Inventor
Victor T Bandurco
Seymour D Levine
Dennis M Mulvey
Alfonso J Tobia
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK449183D0 publication Critical patent/DK449183D0/da
Publication of DK449183A publication Critical patent/DK449183A/da
Publication of DK159311B publication Critical patent/DK159311B/da
Application granted granted Critical
Publication of DK159311C publication Critical patent/DK159311C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00Derivatives of isocyanic acid
    • C07C265/12Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK449183A 1982-09-30 1983-09-29 Analogifremgangsmaade til fremstilling af 5,6-dialkoxy-4-alkyl-2(1h)quinazolinoner DK159311C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43055282 1982-09-30
US06/430,552 US4490374A (en) 1982-09-30 1982-09-30 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use
JP59058527A JPS60204770A (ja) 1982-09-30 1984-03-28 ジヒドロキシ−2(1h)キナゾリノン−1−アルカン酸類
JP5852784 1984-03-28

Publications (4)

Publication Number Publication Date
DK449183D0 true DK449183D0 (da) 1983-09-29
DK449183A DK449183A (da) 1984-03-31
DK159311B DK159311B (da) 1990-10-01
DK159311C DK159311C (da) 1991-03-11

Family

ID=26399581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK449183A DK159311C (da) 1982-09-30 1983-09-29 Analogifremgangsmaade til fremstilling af 5,6-dialkoxy-4-alkyl-2(1h)quinazolinoner

Country Status (14)

Country Link
US (1) US4490374A (da)
EP (2) EP0220786B1 (da)
JP (2) JPS5982374A (da)
AU (1) AU563958B2 (da)
CA (1) CA1215712A (da)
DK (1) DK159311C (da)
FI (1) FI833523A (da)
GB (2) GB2127823B (da)
GR (1) GR79366B (da)
HK (2) HK98787A (da)
IE (1) IE56413B1 (da)
PT (1) PT77422B (da)
SU (2) SU1407398A3 (da)
ZA (1) ZA837302B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656267A (en) * 1983-09-29 1987-04-07 Ortho Pharmaceutical Corporation Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters
US4556739A (en) * 1983-09-29 1985-12-03 Ortho Pharmaceutical Corporation 3,4-Dialkoxy-2-alkylcarbonyl analino compounds
US4617392A (en) * 1983-09-29 1986-10-14 Ortho Pharmaceutical Corporation 4-alkyl-5,6-methylenedioxy-2-1[H]-quinazolinones useful as cardiotonic agents
US4731480A (en) 1985-07-29 1988-03-15 Ortho Pharmaceutical Corporation Process for preparing 2-acyl-3,4-dialkoxyanilines
KR900003529B1 (ko) 1985-07-29 1990-05-21 오르토 파마슈티컬 코포레이션 2-아실-3,4-디알콕시아닐린의 제조방법
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US4975428A (en) * 1988-05-31 1990-12-04 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) * 1991-08-16 1993-03-16 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
US6749598B1 (en) 1999-01-11 2004-06-15 Flowmedica, Inc. Apparatus and methods for treating congestive heart disease
US7122019B1 (en) 2000-11-28 2006-10-17 Flowmedica Inc. Intra-aortic renal drug delivery catheter
US7329236B2 (en) 1999-01-11 2008-02-12 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7481803B2 (en) 2000-11-28 2009-01-27 Flowmedica, Inc. Intra-aortic renal drug delivery catheter
US7780628B1 (en) 1999-01-11 2010-08-24 Angiodynamics, Inc. Apparatus and methods for treating congestive heart disease
US6982260B1 (en) 1999-11-22 2006-01-03 Warner-Lambert Company Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes
JP2003514901A (ja) * 1999-11-22 2003-04-22 ワーナー−ランバート・カンパニー キナゾリン類およびシクリン依存性キナーゼ酵素を阻害するためのその使用
US20050197624A1 (en) 2004-03-04 2005-09-08 Flowmedica, Inc. Sheath for use in peripheral interventions
US7063679B2 (en) 2002-09-20 2006-06-20 Flowmedica, Inc. Intra-aortic renal delivery catheter
AU2003276903A1 (en) 2002-09-20 2004-05-04 Flowmedica, Inc. Method and apparatus for selective material delivery via an intra-renal catheter
US7993325B2 (en) 2002-09-20 2011-08-09 Angio Dynamics, Inc. Renal infusion systems and methods
EP1585572A4 (en) 2002-09-20 2010-02-24 Flowmedica Inc METHOD AND APPARATUS FOR ADMINISTERING INTRA-AORTIC SUBSTANCE TO A BRANCHED VESSEL
EP1624909A2 (en) 2002-09-20 2006-02-15 FlowMedica, Inc. Appartus and method for inserting an intra-aorta catheter trough a delivery sheath
JP2006526464A (ja) 2003-06-05 2006-11-24 フローメディカ,インコーポレイテッド 分枝した身体管腔において両側介入または診断を行うためのシステムおよび方法
JP2007537298A (ja) 2004-05-14 2007-12-20 フロウメディカ, インコーポレイテッド うっ血性心不全の処置およびbnp療法のための両側性局所腎臓送達
US7771401B2 (en) 2006-06-08 2010-08-10 Angiodynamics, Inc. Selective renal cannulation and infusion systems and methods
KR101691954B1 (ko) * 2016-04-26 2017-01-02 고려대학교 산학협력단 신규 n-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1280551A (en) * 1968-07-01 1972-07-05 Sandoz Ltd Quinazoline derivatives
US3859237A (en) * 1970-04-20 1975-01-07 Sumitomo Chemical Co Quinazoline derivatives
US3950526A (en) * 1970-04-20 1976-04-13 Sumitomo Chemical Company, Limited Quinazoline derivatives in pharmaceutical compositions for treating pain and inflammation
DE2118315C3 (de) * 1970-04-20 1975-04-03 Sumitomo Chemical Co., Ltd., Osaka (Japan) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE392616B (sv) * 1971-06-29 1977-04-04 Sumitomo Chemical Co Forfarande for framstellning av kinazolinonforeningar
JPS4887012A (da) * 1972-02-21 1973-11-16
JPS5013271B2 (da) * 1971-10-04 1975-05-19
JPS4948957B2 (da) * 1971-10-26 1974-12-24
JPS555506B2 (da) * 1972-09-07 1980-02-07
JPS5217842A (en) * 1975-07-31 1977-02-10 Canon Inc Device for fabricating sound hologram
AU533427B2 (en) * 1978-12-07 1983-11-24 Ortho Pharmaceutical Corporation Substituted 2(1h) quinazolinones
GB2039895B (en) * 1978-12-07 1983-03-02 Ortho Pharma Corp 4-substituted-2(1h)quinazolinones
ZA796623B (en) * 1978-12-07 1981-07-29 Ortho Pharma Corp Substituted pyrrolo (1,2-c) quinazolines

Also Published As

Publication number Publication date
HK98787A (en) 1987-12-31
CA1215712A (en) 1986-12-23
SU1344246A3 (ru) 1987-10-07
GB2163426A (en) 1986-02-26
US4490374A (en) 1984-12-25
IE56413B1 (en) 1991-07-31
EP0107398A1 (en) 1984-05-02
IE832307L (en) 1984-03-30
JPS5982374A (ja) 1984-05-12
DK159311C (da) 1991-03-11
EP0107398B1 (en) 1988-06-08
GR79366B (da) 1984-10-22
GB8326030D0 (en) 1983-11-02
DK449183A (da) 1984-03-31
EP0220786A2 (en) 1987-05-06
FI833523A (fi) 1984-03-31
EP0220786A3 (en) 1988-02-24
DK159311B (da) 1990-10-01
PT77422B (en) 1986-09-10
GB8519309D0 (en) 1985-09-04
AU563958B2 (en) 1987-07-30
FI833523A0 (fi) 1983-09-29
EP0220786B1 (en) 1990-11-22
GB2127823A (en) 1984-04-18
JPS60204770A (ja) 1985-10-16
GB2163426B (en) 1987-01-07
AU1979483A (en) 1984-04-05
SU1407398A3 (ru) 1988-06-30
ZA837302B (en) 1985-05-29
PT77422A (en) 1983-10-01
HK98887A (en) 1987-12-31
GB2127823B (en) 1987-01-07

Similar Documents

Publication Publication Date Title
DK449183D0 (da) Fremgangsmade til fremstilling af ortho-substituerede dihydroxy-2(1h)quinazolinon-1-alkansyrer
DK434381A (da) Fremgangsmaade til fremstilling af substituerede imonodicarboxylsyrer
DK144783A (da) Fremgangsmaade til fremstilling af cycloalka(c)pyrrol-carboxylsyrederivater
DK160502C (da) Fremgangsmaade til fremstilling af en 7beta-malonamido-7alfa-methoxy-3-tetrazolylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyreester
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
DK103583D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK103683D0 (da) Fremgangsmade til fremstilling af 2-keto-l-gulonsyre
DK540781A (da) Fremgangsmaade til fremstilling af 2-hydronaphthalen-6-carboxylsyre
DK218183A (da) Fremgangsmaade til fremstilling af 2(1h)-pyridinon-derivater
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK508881A (da) Fremgangsmaade til fremstilling af oploesninger af 7-amincophelosporansyrer
DK158312C (da) Fremgangsmaade til fremstilling af diacetoneketogulonsyre
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
DK157677C (da) Fremgangsmaade til fremstilling af cyclopropancarboxylsyreesterderivater
DK60081A (da) Fremgangsmaade til fremstilling af diphenylethercarboxylsyrer
DK399783A (da) Fremgangsmaade til fremstilling af substituerede 1-pyridyloxy-3-indolylalkylamino-2-propanoler
DK163667C (da) Fremgangsmaade til fremstilling af 7-amino-3-chlor-3-cephem-4-carboxylsyreestere
DK518883A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactam-forbindelser
DK145741C (da) Fremgangsmaade til fremstilling af 6-chlor-alfa-methyl-carbazol-2-eddikesyre
DK228583D0 (da) Fremgangsmade til fremstilling af 5-oxo-2-pyrrolidinpropansyrederivater
DK157613C (da) Fremgangsmaade til fremstilling af cyclopropancarboxylsyreesterderivater
DK179183A (da) Fremgangsmaade til fremstilling af hydroxymethylbutensyrer
DK293281A (da) Fremgangsmaade til fremstilling af 3-acylazopropionsyreestere
DK432683D0 (da) Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer
DK553781A (da) Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosulthiazol-4-carboxid-estere

Legal Events

Date Code Title Description
PBP Patent lapsed